High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas.

Medical Oncology
Ze-Xiao LinHui-Qiang Huang

Abstract

Various studies on lymphoma microenvironment have demonstrated the prognostic impact of tumor-associated macrophages (TAMs) in patients with B-cell lymphoma. Little is known about the correlation between TAMs and treatment outcome in mature T- and natural killer (NK) cell lymphomas. We analyzed the prognostic relevance of CD68+ TAMs by immunohistochemical analysis in 64 Chinese patients with mature T- and NK-cell lymphomas. Higher number of infiltrated TAMs was significantly related to B symptoms and extranodal involvement (p < 0.05). The TAMs content did not differ significantly between pathological subtypes. Using the mean value of TAMs per high-power field (hpf) as the cutoff point (87/hpf), 36 cases (56.2 %) were categorized as low level of TAMs content and 28 cases (43.8%) as high level. Patients with high level of TAMs content had a worse 5-year overall survival compared to those with low level (28.1 vs. 44.3 %, p = 0.039). In multivariate analysis, TAMs content remained an independent biological variable for survival distinct from the International Prognostic Index (Cox multivariate model, p = 0.009). High TAMs content indicated an adverse overall outcome in mature T- and NK-cell lymphomas. Our results show that expressi...Continue Reading

References

Feb 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T RüdigerUNKNOWN Non-Hodgkin's Lymphoma Classification Project
Nov 19, 2004·The New England Journal of Medicine·Sandeep S DaveLouis M Staudt
Jan 21, 2006·Cancer Research·Claire E Lewis, Jeffrey W Pollard
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomás AlvaroLluis E Pons
Oct 5, 2007·Critical Reviews in Oncology/hematology·Paola AllavenaAlberto Mantovani
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Danielle CanioniLuc Xerri
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Dec 17, 2008·Annales de pathologie·Georges Delsol
Dec 17, 2008·Cancer Chemotherapy and Pharmacology·Flaubert Mbeunkui, Donald J Johann
May 12, 2009·Immunology Letters·K S Siveen, Girija Kuttan
Jun 25, 2009·Cell Cycle·Tamas A GondaTimothy C Wang
Dec 8, 2009·Blood·Javeed IqbalUNKNOWN International Peripheral T-Cell Lymphoma Project
Feb 6, 2010·Blood·Christian Gisselbrecht
Jan 4, 2012·Histopathology·Naoki WadaUNKNOWN Osaka Lymphoma Study Group

❮ Previous
Next ❯

Citations

Oct 15, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liang WangYu-jing Zhang
Jun 10, 2015·Seminars in Cancer Biology·Eric Tse, Yok-Lam Kwong
Jul 23, 2016·Pathology International·Motohiro Takeya, Yoshihiro Komohara
Mar 22, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yun ShiZhiqiang An
Apr 7, 2020·Nature Reviews. Cancer·Danilo FioreGiorgio Inghirami
Feb 8, 2018·Annual Review of Pathology·Marco PizziGiorgio Inghirami
Aug 28, 2021·Life·Jason Yongsheng ChanChoon Kiat Ong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.